Selinexor-based treatments are associated with increased expression of T-cell activation markers in multiple myeloma
Abstract: Many currently approved therapies for multiple myeloma (MM) use the endogenous immune system. The indirect effects of cytotoxic antimyeloma agents on the immune microenvironment can impact on the success of subsequent or combined immune-directed therapies. In this study, we investigated th...
保存先:
| 主要な著者: | , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier
2025-12-01
|
| シリーズ: | Blood Immunology & Cellular Therapy |
| オンライン･アクセス: | http://www.sciencedirect.com/science/article/pii/S3050597625000090 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|